These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1641486)

  • 1. [Positron emission tomography of the thorax. The current clinical status].
    Knopp MV; Bischoff H; Oberdorfer F; van Kaick G
    Radiologe; 1992 Jun; 32(6):290-5. PubMed ID: 1641486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose.
    Rege SD; Hoh CK; Glaspy JA; Aberle DR; Dahlbom M; Razavi MK; Phelps ME; Hawkins RA
    Cancer; 1993 Jul; 72(1):82-90. PubMed ID: 8389668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography, bronchogenic carcinoma, and the adrenals.
    Lamki LM
    AJR Am J Roentgenol; 1997 May; 168(5):1361-2. PubMed ID: 9129445
    [No Abstract]   [Full Text] [Related]  

  • 4. Introduction to clinical positron emission tomography.
    Agress H
    N J Med; 2000 Oct; 97(10):25-30. PubMed ID: 11064564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG positron emission tomography in lymphoma.
    Tecnologica MAP Suppl; 2000 Jan; ():9-10. PubMed ID: 10848116
    [No Abstract]   [Full Text] [Related]  

  • 6. Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography.
    Bares R; Galonska P; Dempke W; Handt S; Büll U; Osieka R
    Horm Metab Res Suppl; 1993; 27():56-8. PubMed ID: 8330873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorine-18 fluorodeoxyglucose positron emission tomography for lymphoma: incorporating new technology into clinical care.
    Kaplan LD
    Am J Med; 2002 Mar; 112(4):320-1. PubMed ID: 11893374
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.
    Patz EF; Lowe VJ; Hoffman JM; Paine SS; Harris LK; Goodman PC
    Radiology; 1994 May; 191(2):379-82. PubMed ID: 8153309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of positron emission tomography in treatment of lymphoma patients].
    Kuwert T
    Strahlenther Onkol; 2001 Mar; 177(3):160-1. PubMed ID: 11285774
    [No Abstract]   [Full Text] [Related]  

  • 10. The status of SPECT in tumor diagnosis.
    DeLand FH; Shih WJ
    J Nucl Med; 1984 Dec; 25(12):1375-9. PubMed ID: 6389792
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.
    Ichiya Y; Kuwabara Y; Otsuka M; Tahara T; Yoshikai T; Fukumura T; Jingu K; Masuda K
    J Nucl Med; 1991 Sep; 32(9):1655-60. PubMed ID: 1880564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar pelvic abnormalities on FDG positron emission tomography of different origins.
    Zhuang H; Yamamoto AJ; Sinha P; Pourdehnad M; Liu Y; Alavi A
    Clin Nucl Med; 2001 Jun; 26(6):515-7. PubMed ID: 11353298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy.
    Hoekstra OS; Ossenkoppele GJ; Golding R; van Lingen A; Visser GW; Teule GJ; Huijgens PC
    J Nucl Med; 1993 Oct; 34(10):1706-10. PubMed ID: 8410287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluorodeoxyglucose and bronchopulmonary cancer. Initial French results with positron emission tomography].
    Vaylet F; Foehrenbach H; De Dreuille O; Maszelin P; Merlet P; Bendriem B; L'Her P; Syrota A; Gaillard JF
    Rev Pneumol Clin; 1998 Sep; 54(4):187-95. PubMed ID: 9805748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [18F]fluorodeoxyglucose positron emission tomography in the management of lymphomas.
    Kostakoglu L
    Clin Lymphoma Myeloma; 2008 Oct; 8(5):273-6. PubMed ID: 18854280
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnostic techniques for bronchial cancer. New scintigraphic techniques (immunoscintigraphy and positron-emission tomography)].
    Vaylet F; Vuillez JP
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S78-82. PubMed ID: 10088259
    [No Abstract]   [Full Text] [Related]  

  • 17. Thoracic actinomycosis imaging with fluorine-18 fluorodeoxyglucose positron emission tomography.
    Hoekstra CJ; Hoekstra OS; Teengs JP; Postmus PE; Smit EF
    Clin Nucl Med; 1999 Jul; 24(7):529-30. PubMed ID: 10402013
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis.
    Okada J; Yoshikawa K; Imazeki K; Minoshima S; Uno K; Itami J; Kuyama J; Maruno H; Arimizu N
    J Nucl Med; 1991 Apr; 32(4):686-91. PubMed ID: 2013808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography in the management of lymphomas: a summary.
    O'Doherty MJ; Hoskin PJ
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S128-30. PubMed ID: 12692689
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of pulmonary lesions with positron emission tomography].
    Knopp MV; Bischoff HG
    Radiologe; 1994 Oct; 34(10):588-91. PubMed ID: 7816916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.